Patent Yard Sign in
Expired Canadian patentCanada

Hyperspectral imaging in diabetes and peripheral vascular disease

CA 2604829 C · Owner: Hypermed, Inc. · Inventors: Panasyuk, Svetlana V.; Hopmeier, Michael; Freeman, Jenny E.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention is directed to methods and systems of hyperspectral and multispectral imaging of medical tissues. In particular the invention is , directed to new devices tools and processes for the detection and evaluation of diseases and disorders such as, but not limited to diabetes and peripheral vascular disease, that incorporate hyperspectral or multispectral imaging.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed April 4, 2006 and granted May 15, 2018. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 4, 2026.
  • Certificates of supplementary protection extend only drug patents, and it isn't classified as one.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledApril 4, 2006
GrantedMay 15, 2018
Term endedApril 4, 2026
Patent numberCA 2604829 C
Classification (IPC)—

Timeline

Timeline From CIPO dates

2007200920112013201520172019202120232025Application filedApril 4, 2006Patent grantedMay 15, 2018Term endedApril 4, 2026

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.